eMedicine Specialties > Plastic Surgery > Facial Augmentation

Facial Alloplastic Implants, Chin: Treatment

Author: John A Grossman, MD, Emeritus Chairman, Instructor, Departments of Otolaryngology and Plastic Surgery, University of Colorado Rose Medical Center
Contributor Information and Disclosures

Updated: Sep 10, 2008

Treatment

Medical Therapy

No appropriate medical therapy is available.

Surgical Therapy

The surgical treatment of microgenia includes procedures beyond the purview of this article and can be found elsewhere in eMedicine (see Craniofacial, Orthognathic Surgery). These techniques include orthognathic advancements of the mandible and/or chin, including the simplest technique, sliding genioplasty; nonalloplastic and/or autogenous implantation; and alloplastic chin implantation. The last of these, discussed in this article, corrects microgenia with the use and insertion of alloplastic implant materials.

Conceptually, a space is created over the surface of chin (mentum), and an implant is placed in this space. The list of types of alloplastic materials available and those that have been used is quite extensive and includes silicone, Proplast, Teflon, Dacron, Gore-Tex, Mersilene mesh, acrylic, porous polyethylene (Medpor), Proplast I and II, methylmethacrylate, and hydroxyapatite. The most commonly used alloplastic implant material is silicone. Technically, the procedure for implantation is basically the same regardless of implant material type.

Preoperative Details

The preoperative regimen varies with physician preference. The author reviews the surgical plan with the patient during the week prior to the scheduled surgical date. At this time, the course of surgery, postoperative instructions, and surgical risks are discussed. The patient has the opportunity to have questions answered, and the surgical consent is signed.

For 2 weeks before and after surgery, patients are asked to eliminate all medications, vitamins, and food supplements that have not been authorized specifically by the surgeon and/or his or her staff. Alcohol, aspirin, aspirin-containing medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and the complete list of drugs that may inhibit platelet aggregation and clotting must be eliminated.

For 2 days prior to surgery, patients are requested to use an antibacterial facial cleanser for face washing when an external incision is planned and mouthwash 3 times daily when an intraoral incision is planned.

Whether a local or general anesthetic is planned, patients must have nothing by mouth for at least 8 hours prior to surgery.

Intraoperative Details

Technically, essentially 2 surgical approaches are available, the intraoral and the external (submental). The author prefers the external or submental approach for a number of reasons. It reduces the incidence of postoperative infection, and the patient's healing process is simpler, shorter, and easier. The disadvantage, of course, is the presence of a visible, albeit small, scar in the submental region.

As mentioned earlier, many types of implants and implant materials are available. However, probably the most commonly used alloplastic chin implant is made of pliable solid silicone. These implants are available in a variety of shapes and sizes. In general, the most natural and appropriate of these for routine chin enhancement is in the anatomic shape.

The surgery routinely is performed on an outpatient basis. Either local or general anesthesia is suitable, although the author prefers a general anesthetic because it provides a more controlled and predictable situation.

Procedure

Following induction of anesthesia, infiltrate the planned incision site and surrounding area of dissection with a local anesthetic agent with epinephrine (usually 0.5% lidocaine with epinephrine 1:200,000). This provides hemostasis, but it also reduces the magnitude and/or depth of general anesthesia necessary. Next, wash the facial region with a mild soap (eg, Castile soap, baby shampoo) and paint the chin region with topical antiseptic solution.

Submental approach

  • Place the incision just inferior to the natural submental crease. Placement in the crease leads to a depression and ultimately may produce a witch's chin deformity.
  • Placing some traction superiorly, proceed with the dissection through the soft tissue to the inferior surface of the chin (mentum) and at the insertion of the mentalis muscle.
  • Incise the periosteum and, using a periosteal elevator, develop a subperiosteal pocket. The pocket's position, whether directly over the leading edge of the chin (as is most often the appropriate location) or slightly above toward the labiomental sulcus on the flat surface, is determined by the desired or needed improvement. Approximating the size and preferred position of the implant by employing sterile implant sizers is useful. Laying a sizer over the chin and outlining it on the skin allows the surgeon initially to dissect a pocket that is not excessively large. Anatomically shaped sizers are meant to be resterilized for repeated use. With the pocket developed, the sizer then can be inserted into this space to obtain a general idea of the best implant size.
  • Once a determination is made and an implant is selected, any additional necessary dissection can be performed.
  • When performing the dissection, keep the elevator against the surface of the bone at all times. The pocket should extend just to the inferior edge of the mandible.
  • Take care to avoid slipping below this edge or into the soft tissue inferiorly or lateral for fear of injury to the marginal mandibular nerve. This nerve, a branch of the facial (seventh cranial) nerve, travels inferior to the edge of the mandible until it crosses the mandible just anterior to the mid point of the horizontal ramus of the mandible. Technically, while dissecting with the periosteal elevator, keeping the index finger of the opposite hand on the inferior border to guide and ensure the elevator's position at all times is helpful.
  • The mental nerve emanates from the bone approximately 1 cm above the edge of the mandible and approximately 2.5-3.5 cm from the mid line. It should be visible, with retraction, through the submental incision. Keeping this in mind, avoiding injury to either nerve in the dissection should be possible.
  • Position the implant inferior to the mental nerve. Once the pocket is developed and bleeding is controlled, irrigate the space with topical antiseptic solution and insert the sterile implant into the space. Handle the implant minimally.
  • Once the implant is in place, any adjustments to pocket dimensions or implant position can be made. The blue marker that delineates the middle on most implants facilitates positioning of the implant in the mid line. Align this point with the central mental tubercle. Close the wound.
  • The author prefers to place a central suture that begins the closure of the periosteum through the implant to stabilize it in position. The wound usually is closed in multiple layers with a final intradermal pullout suture for the skin.
  • Dress the wound with Steri-Strips; other Steri-Strips or tape can be used to support the area. No other dressing is necessary.

Intraoral approach

Coburn states, "Since Converse (1950) demonstrated the safety and feasibility of introducing autogenous bone grafts through intraoral incisions, this approach has been widely used."1

  • Prepare the mouth with mouthwash for several days.
  • Following induction of anesthesia, instill local lidocaine with adrenaline into oral mucosa in the buccal-gingival sulcus and for approximately 1.5 cm above the sulcus on the labial side and into the adjacent gumline. Then, reprep the mouth with topical antiseptic solution.
  • Make an incision on the labial side of the sulcus, leaving a cuff of labial mucosa to create a secure closure. The mucosal incision should be transverse.
  • While many surgeons perform the rest of the dissection via a transverse incision through muscle to bone, consider making the muscular incision and/or dissection vertically and then dividing the midline raphe of the mentalis muscles vertically.
  • Rapidly proceed with the dissection to the bone and create a subperiosteal pocket. The dissection is similar to the external approach. Be careful to dissect inferiorly enough to make the pocket extend along the inferior edge of the mandible.
  • It must be clear that the soft tissue and musculature are released sufficiently so that the implant is seated properly in the desired position along the inferior border of the chin.
  • With bleeding meticulously controlled, irrigate the space with topical antiseptic solution and insert the selected implant.
  • Close the space in a multilayer fashion including periosteum. For the mucosal closure, select a suture that is soft, pliable (eg, silk, Vicryl), and nonirritating to the gums.

Postoperative Details

Postoperative instructions include the following:

  • Eat a soft diet.
  • Elevate the head of the bed or use 2-3 pillows.
  • Limit touching or manipulating the chin area.
  • Practice good oral hygiene (for patients with intraoral approach).
    • Gentle irrigation with antiseptic mouthwash and lukewarm water 2-3 times daily
    • No use of toothbrush around lower central incisors
    • Keep tongue away from incision
  • Take prescribed antibiotics for 1 week.
  • Tale pain medication as needed.
  • Continue normal (but not strenuous) exercise for 2 weeks.

Remove sutures 5-7 days postsurgery for external sutures and 7-10 days postsurgery for intraoral sutures.

Follow-up

Provide follow-up care as appropriate for any aesthetic surgical patient. Generally, barring any unforeseen circumstances or complications, see the patient weekly for the first month, then at 3 months, 6 months, and 1 year postsurgery. Subsequent follow-up care or recall is on an as-needed basis.

Complications

Complications of this surgery can be divided into those that are immediate and those that occur weeks or years later.

Immediate complications

  • Bleeding: Bleeding can occur within hours to several days postoperatively with the formation of a tense or expanding hematoma that threatens the integrity of the skin overlying the implant. This necessitates surgical exploration with evacuation of hematoma and control of bleeding.
  • Nerve injury with either paralysis or loss of sensation: Injury to one or both mental nerves causes alteration or loss of sensation of the chin and lower lip on the injured side(s). Realistically, no other action can be taken but to wait and observe whether sensation returns. This may take days to several months. However, one cause of anesthesia is malposition of the implant with pressure on the mental nerve. If the end of the implant on the anesthetic side is not palpable in the correct position, surgical exploration may be indicated after several weeks of persistent anesthesia.
  • Paralysis: Injury to one or both marginal mandibular branches of the facial nerve results in paralysis. To cause such an injury, dissection would have had to be inferior to the lower mandibular border and off the surface of the bone. Even then, the injury is likely to cause only transient neurapraxia. Obviously, if a nerve transsection may have occurred, initiate immediate microsurgical nerve repair.
  • Malposition of implant: This problem should be infrequent as an immediate complication, since the implant has sufficient landmarks and markers so that with direct vision placement of the implant, the exact placement of the implant should be clear.

Delayed complications

  • Infection: Infection following mentoplasty, especially using the external incision, is quite unusual (<1%). As expected, infection is more common when the intraoral route is used. Incidence also is higher with certain implant materials than with others; it is lowest with commercially produced solid silicone implants. Solid silicone implants that have been carved by the surgeon from a block of silicone have a higher incidence of infection, as do porous implants such as those made of Teflon, Dacron, Mersilene, Gore-Tex, and similar materials. Infection around implants is not eliminated by antibiotic therapy; thus, remove the implant. Reimplantation can be performed at a later date once all evidence of infection is gone. This may be several weeks to 3 months later.
  • Postinfection deformity: Chin deformity following implant removal has been reported. Therefore, planning reimplantation following resolution of infection or subsequent osseous genioplasty (sliding genioplasty) may be important.
  • Malposition: Besides malposition immediately following surgery caused by technical error, the forces of scar capsule formation around the implant can cause movement leading to malposition.
  • Implant extrusion: This is an unusual complication of inadequate soft-tissue coverage; it is more likely to occur with an intraoral incision, especially if inadequate dissection of the pocket along the lower border of the chin occurred.
  • Implant mobility: Together with the natural formation of a periprosthetic capsule, subperiosteal dissection should keep the implant immobile.
  • Bone resorption: This phenomenon probably occurs with all types of chin implants. However, according to Terino, "… studies have failed to reveal pathologic, functional, or even aesthetic consequences."

More on Facial Alloplastic Implants, Chin

Overview: Facial Alloplastic Implants, Chin
Workup: Facial Alloplastic Implants, Chin
Treatment: Facial Alloplastic Implants, Chin
Follow-up: Facial Alloplastic Implants, Chin
Multimedia: Facial Alloplastic Implants, Chin
References

References

  1. Coburn RJ, Rees TD, Horowitz S. Mentoplasty. In: Rees TD, ed. Aesthetic Plastic Surgery. Vol 2. Philadelphia, PA: WB Saunders Co; 1980:770.

  2. Cohen SR. Genioplasty. In: Guyuron B et al, eds. Plastic Surgery: Indications, Operations, and Outcomes. St Louis: Mosby; 2000:2683-2686.

  3. Rubin, LR, Robertson, GW, Shapiro, RN. Polyethylene in reconstructive surgery. Plast Reconstr Surg. 1948;3:586.

  4. Binder WJ, Kamer FM, Parkes ML. Mentoplasty--a clinical analysis of alloplastic implants. Laryngoscope. Mar 1981;91(3):383-91. [Medline].

  5. Cohen SR, Mardach OL, Kawamoto HK Jr. Chin disfigurement following removal of alloplastic chin implants. Plast Reconstr Surg. Jul 1991;88(1):62-6; discussion 67-70. [Medline].

  6. Eppley BL. Alloplastic implantation. Plast Reconstr Surg. Nov 1999;104(6):1761-83; quiz 1784-5. [Medline].

  7. Eppley BL, Sadove AM, Holmstrom H, et al. HTR polymer facial implants: a five-year clinical experience. Aesthetic Plast Surg. Sep-Oct 1995;19(5):445-50. [Medline].

  8. Guyuron B, Raszewski RL. A critical comparison of osteoplastic and alloplastic augmentation genioplasty. Aesthetic Plast Surg. Summer 1990;14(3):199-206. [Medline].

  9. Karras SC, Wolford LM. Augmentation genioplasty with hard tissue replacement implants. J Oral Maxillofac Surg. May 1998;56(5):549-52. [Medline].

  10. Kobayashi T, Shingaki S, Nakajima T, et al. Chin augmentation with porous hydroxyapatite blocks. J Long Term Eff Med Implants. 1993;3(4):283-94. [Medline].

  11. Matarasso A, Elias AC, Elias RL. Labial incompetence: a marker for progressive bone resorption in silastic chin augmentation. Plast Reconstr Surg. Nov 1996;98(6):1007-14; discussion 1015. [Medline].

  12. McCollough EG, Hom DB, Weigel MT, et al. Augmentation mentoplasty using Mersilene mesh. Arch Otolaryngol Head Neck Surg. Oct 1990;116(10):1154-8. [Medline].

  13. Moenning JE, Wolford LM. Chin augmentation with various alloplastic materials: a comparative study. Int J Adult Orthodon Orthognath Surg. 1989;4(3):175-87. [Medline].

  14. Peled IJ, Wexler MR. Screw fixation of silicone implants. Ann Plast Surg. Aug 1987;19(2):195-6. [Medline].

  15. Peterson RA. Correction of the senile chin deformity in face lift. Clin Plast Surg. Apr 1992;19(2):433-45. [Medline].

  16. Pitanguy I, Martello L, Caldeira AM, et al. Augmentation mentoplasty: a critical analysis. Aesthetic Plast Surg. 1986;10(3):161-9. [Medline].

  17. Salman L, Kinney LA. Clinical response of hard tissue replacement (HTR) polymer as an implant material in oral surgery patients. J Oral Implantol. 1992;18(1):24-8. [Medline].

  18. Terino EO. Alloplastic facial contouring by zonal principles of skeletal anatomy. Clin Plast Surg. Apr 1992;19(2):487-510. [Medline].

  19. Terino EO, Flowers RS. Alloplastic contouring in the premandible-jawline lower third facial unit. In: Terino Eo, Flowers RS, eds. The Art of Alloplastic Facial Contouring. St Louis: Mosby; 2000:153-163.

  20. Toranto IR. Mentoplasty: a new approach. Plast Reconstr Surg. May 1982;69(5):875-8. [Medline].

  21. Vuyk HD. Augmentation mentoplasty with solid silicone. Clin Otolaryngol Allied Sci. Apr 1996;21(2):106-18. [Medline].

Further Reading

Keywords

chin implant, facial alloplastic implant, facial implant, mentoplasty, augmentation mentoplasty, chin augmentation, small chin, weak chin, chin surgery, genioplasty, chinplasty, profileplasty

Contributor Information and Disclosures

Author

John A Grossman, MD, Emeritus Chairman, Instructor, Departments of Otolaryngology and Plastic Surgery, University of Colorado Rose Medical Center
John A Grossman, MD is a member of the following medical societies: American Burn Association, American Medical Association, American Society for Aesthetic Plastic Surgery, American Society for Laser Medicine and Surgery, American Society of Plastic Surgeons, Colorado Medical Society, Lipoplasty Society of North America, and Pan-Pacific Surgical Association
Disclosure: Nothing to disclose.

Medical Editor

Gregory Caputy, MD, PhD, Chief, Department of Plastic Surgery, Aesthetica Plastic and Laser Surgery Center of Honolulu
Gregory Caputy, MD, PhD is a member of the following medical societies: American Medical Association, American Society for Laser Medicine and Surgery, Canadian Medical Association, Hawaii Medical Association, International College of Surgeons, International College of Surgeons US Section, Pan-Pacific Surgical Association, and Wound Healing Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Edward Owen Terino, MD, Director, Department of Plastic Surgery, Los Robles Medical Center
Edward Owen Terino, MD is a member of the following medical societies: American College of Surgeons, American Society for Aesthetic Plastic Surgery, and International College of Surgeons
Disclosure: Nothing to disclose.

CME Editor

Nicolas (Nick) G Slenkovich, MD, Practice Director, Colorado Plastic Surgery Center at Swedish Medical Center
Nicolas (Nick) G Slenkovich, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Society of Plastic Surgeons, and Colorado Medical Society
Disclosure: Nothing to disclose.

Chief Editor

Al Aly, MD, FACS, Consulting Surgeon, Iowa City Plastic Surgery
Disclosure: Ethicon  Consulting fee Consulting; QMP Royalty Book royalty; Insorb Stapler Consulting fee Consulting; Insorb Stapler Ownership interest None; Medicis Intellectual property rights None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.